s20098 has been researched along with Diabetic Neuropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayar, A; Bulmus, FG; Bulmus, O; Canpolat, S; Etem, EO; Kelestimur, H; Oruc, S; Ozcan, M; Ozcan, S; Ulker, N; Yardimci, A | 1 |
| Aydın, TH; Can, ÖD; Demir Özkay, Ü; Turan, N | 1 |
2 other study(ies) available for s20098 and Diabetic Neuropathies
| Article | Year |
|---|---|
Agomelatine potentiates anti-nociceptive effects of morphine in a mice model for diabetic neuropathy: involvement of NMDA receptor subtype NR1 within the raphe nucleus and periaqueductal grey.
Topics: Acetamides; Analgesics; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Drug Tolerance; Male; Mice; Mice, Inbred BALB C; Morphine; Periaqueductal Gray; Raphe Nuclei; Receptors, N-Methyl-D-Aspartate | 2020 |
Effect of subacute agomelatine treatment on painful diabetic neuropathy: involvement of catecholaminergic mechanisms.
Topics: Acetamides; Animals; Blood Glucose; Catecholamines; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Fenclonine; Hyperalgesia; Hyperglycemia; Methyltyrosines; Neuralgia; Phentolamine; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Streptozocin | 2016 |